Has online prescribing improved medical cannabis care in Germany? Bertan Türemis will join a Frankfurt debate on telemedicine, prescribing standards and patient safety.
Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products.
Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients.
Pharmacist Nitin Makadia will discuss safer prescribing and lessons from European medical cannabis care at Frankfurt’s symposium on 4 November.
Ahead of Frankfurt’s Cannabis Health Symposium, Professor Bernd Werse discusses changing cannabis use and the evidence policymakers still need.
Lisa Katharina Haag will bring her perspective on cannabis policy and patient care to the one-day event.
Dr Julian Wichmann will discuss patient assessments, follow-up care and responsibility for treatment.
Professor Bernd Werse will join a debate examining the evidence behind cannabis policy on 4 November.
The pharmaceutical industry representative will examine treatment costs and what policy changes mean for patients.
Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next.
Professor Sylvia Mechsner will examine the evidence for medical cannabis in women’s health on 4 November.
The European Medicinal Cannabis Association’s general secretary will join a debate on how research informs cannabis policy in less than two weeks time.
Changes to Germany’s health insurance rules have left patients facing new limits on funded cannabis treatment. Cannabis Health explains the rules and the industry’s objections.
Doctors, pharmacists and researchers will meet in Frankfurt on 4 November to discuss changes affecting medical cannabis treatment. With two weeks to go, here’s what’s on the programme and how to book…
Plans for greater scrutiny and monitoring have been broadly welcomed, but some patients fear a “knee-jerk” reaction and say cannabis is not the “whole story”.
Online services have made medical cannabis easier to get hold of in Germany – but are patients getting the medical checks they need? Would tighter rules make prescribing safer or just leave patients struggling to find a doctor and get their medicine? Cannabis Health explores the debate…
Campaigner Lara Smith is bringing patients together to challenge a “cruel” system she says leaves them struggling to afford “life-changing” treatment.
A researcher specialising in the social and cultural factors that shape health and medicine has been announced as a speaker at a medical cannabis conference in London next month.
A pharmaceutical executive leading work on international cannabis standards will speak at medical cannabis conferences in Frankfurt and London this autumn.
A former Frankfurt drugs official will examine how stigma around cannabis can affect patients receiving it as a medical treatment at a conference in the city next month.
Whether cannabinoid medicines could offer a better overall treatment option than opioids for some people with chronic pain will be examined at a medical cannabis conference in Frankfurt this November.
What is actually legal when it comes to medical cannabis in the UK? From prescriptions and possession to driving, smoking and NHS access, here’s what patients need to know about the law in 2026.
The director of the UK’s only World Anti-Doping Agency-accredited laboratory has been announced as a speaker at a medical cannabis conference in London next month.
A data and economics specialist working across Germany’s medical cannabis sector will join the Cannabis Health Symposium Frankfurt later this year.
